Role of human macrophage polarization in inflammation during infectious diseases

International Journal of Molecular Sciences

Volumn 19, Issue 6, 2018, Pages

  Atri, Chiraz ^a,b,c   Guerfali, Fatma Z ^a,b   Laouini, Dhafer ^a,b  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c Struggle and Prevention   (Tunisia)

Author keywords

Human macrophage; Infectious diseases; Inflammation; Leishmaniasis; M1 like M2 like; Polarization

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MANNOSE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PATTERN RECOGNITION RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; INFECTION; INFLAMMATION; INNATE IMMUNITY; LEISHMANIASIS; MACROPHAGE POLARIZATION; MYCOSIS; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PARASITOSIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WOUND HEALING; CELL DIFFERENTIATION; COMMUNICABLE DISEASE; CYTOLOGY; GENETICS; IMMUNOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM;

CELL DIFFERENTIATION; COMMUNICABLE DISEASES; CYTOKINES; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES;

EID: 85048862425     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19061801     Document Type: Review

References (84)

1. Nathan, C. Metchnikoff’s legacy in 2008. Nat. Immunol. 2008, 9, 695–698. [CrossRef] [PubMed]
2. David, J.R. Lymphocyte mediators and cellular hypersensitivity. N. Engl. J. Med. 1973, 288, 143–149. [PubMed]
3. Martinez, F.O.; Helming, L.; Gordon, S. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009, 27, 451–483. [CrossRef] [PubMed]
4. Duffield, J.S.; Lupher, M.; Thannickal, V.J.; Wynn, T.A. Host responses in tissue repair and fibrosis. Annu. Rev. Pathol. 2013, 8, 241–276. [CrossRef] [PubMed]
5. Murray, P.J. Macrophage polarization. Annu. Rev. Physiol. 2017, 79, 541–566. [CrossRef] [PubMed]
6. Zhang, X.; Mosser, D.M. Macrophage activation by endogenous danger signals. J. Pathol. 2008, 214, 161–178. [CrossRef] [PubMed]
7. Xu, W.; Zhao, X.; Daha, M.R.; van Kooten, C. Reversible differentiation of pro-and anti-inflammatory macrophages. Mol. Immunol. 2013, 53, 179–186. [CrossRef] [PubMed]
8. Beyer, M.; Mallmann, M.R.; Xue, J.; Staratschek-Jox, A.; Vorholt, D.; Krebs, W.; Sommer, D.; Sander, J.; Mertens, C.; Nino-Castro, A.; et al. High-resolution transcriptome of human macrophages. PLoS ONE 2012, 7, e45466. [CrossRef] [PubMed]
9. Tarique, A.A.; Logan, J.; Thomas, E.; Holt, P.G.; Sly, P.D.; Fantino, E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am. J. Respir. Cell Mol. Biol. 2015, 53, 676–688. [CrossRef] [PubMed]
10. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25, 677–686. [CrossRef] [PubMed]
11. Vogel, D.Y.; Glim, J.E.; Stavenuiter, A.W.; Breur, M.; Heijnen, P.; Amor, S.; Dijkstra, C.D.; Beelen, R.H. Human macrophage polarization in vitro: Maturation and activation methods compared. Immunobiology 2014, 219, 695–703. [CrossRef] [PubMed]
12. Roussel, M.; Ferrell, P.B., Jr.; Greenplate, A.R.; Lhomme, F.; Le Gallou, S.; Diggins, K.E.; Johnson, D.B.; Irish, J.M. Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow. J. Leukoc. Biol. 2017, 102, 437–447. [CrossRef] [PubMed]
13. Shiratori, H.; Feinweber, C.; Luckhardt, S.; Linke, B.; Resch, E.; Geisslinger, G.; Weigert, A.; Parnham, M.J. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro. Mol. Immunol. 2017, 88, 58–68. [CrossRef] [PubMed]
14. Italiani, P.; Mazza, E.M.; Lucchesi, D.; Cifola, I.; Gemelli, C.; Grande, A.; Battaglia, C.; Bicciato, S.; Boraschi, D. Transcriptomic profiling of the development of the inflammatory response in human monocytes in vitro. PLoS ONE 2014, 9, e87680. [CrossRef] [PubMed]
15. Rackov, G.; Hernandez-Jimenez, E.; Shokri, R.; Carmona-Rodriguez, L.; Manes, S.; Alvarez-Mon, M.; Lopez-Collazo, E.; Martinez, A.C.; Balomenos, D. P21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β. J. Clin. Investig. 2016, 126, 3089–3103. [CrossRef] [PubMed]
16. Suzuki, H.; Hisamatsu, T.; Chiba, S.; Mori, K.; Kitazume, M.T.; Shimamura, K.; Nakamoto, N.; Matsuoka, K.; Ebinuma, H.; Naganuma, M.; et al. Glycolytic pathway affects differentiation of human monocytes to regulatory macrophages. Immunol. Lett. 2016, 176, 18–27. [CrossRef] [PubMed]
17. Hutchinson, J.A.; Riquelme, P.; Sawitzki, B.; Tomiuk, S.; Miqueu, P.; Zuhayra, M.; Oberg, H.H.; Pascher, A.; Lutzen, U.; Janssen, U.; et al. Cutting edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J. Immunol. 2011, 187, 2072–2078. [CrossRef] [PubMed]
18. Guo, F.; Hu, M.; Huang, D.; Zhao, Y.; Heng, B.; Guillemin, G.; Lim, C.K.; Hawthorne, W.J.; Yi, S. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s). Xenotransplantation 2017, 24, e12326. [CrossRef] [PubMed]
19. Riquelme, P.; Amodio, G.; Macedo, C.; Moreau, A.; Obermajer, N.; Brochhausen, C.; Ahrens, N.; Kekarainen, T.; Fandrich, F.; Cuturi, C.; et al. DHRS9 is a stable marker of human regulatory macrophages. Transplantation 2017, 101, 2731–2738. [CrossRef] [PubMed]
20. Erbel, C.; Tyka, M.; Helmes, C.M.; Akhavanpoor, M.; Rupp, G.; Domschke, G.; Linden, F.; Wolf, A.; Doesch, A.; Lasitschka, F.; et al. CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo. Innate Immun. 2015, 21, 255–265. [CrossRef] [PubMed]
21. Boyle, J.J.; Johns, M.; Kampfer, T.; Nguyen, A.T.; Game, L.; Schaer, D.J.; Mason, J.C.; Haskard, D.O. Activating transcription factor 1 directs mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ. Res. 2012, 110, 20–33. [CrossRef] [PubMed]
22. Boyle, J.J.; Harrington, H.A.; Piper, E.; Elderfield, K.; Stark, J.; Landis, R.C.; Haskard, D.O. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 2009, 174, 1097–1108. [CrossRef] [PubMed]
23. Verreck, F.A.; de Boer, T.; Langenberg, D.M.; Hoeve, M.A.; Kramer, M.; Vaisberg, E.; Kastelein, R.; Kolk, A.; de Waal-Malefyt, R.; Ottenhoff, T.H. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 2004, 101, 4560–4565. [CrossRef] [PubMed]
24. Verreck, F.A.; de Boer, T.; Langenberg, D.M.; van der Zanden, L.; Ottenhoff, T.H. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ-and CD40L-mediated costimulation. J. Leukoc. Biol. 2006, 79, 285–293. [CrossRef] [PubMed]
25. Martinez, F.O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 2006, 177, 7303–7311. [CrossRef] [PubMed]
26. Jaguin, M.; Houlbert, N.; Fardel, O.; Lecureur, V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol. 2013, 281, 51–61. [CrossRef] [PubMed]
27. Vogel, D.Y.; Vereyken, E.J.; Glim, J.E.; Heijnen, P.D.; Moeton, M.; van der Valk, P.; Amor, S.; Teunissen, C.E.; van Horssen, J.; Dijkstra, C.D. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J. Neuroinflamm. 2013, 10, 809. [CrossRef] [PubMed]
28. Ambarus, C.A.; Noordenbos, T.; de Hair, M.J.; Tak, P.P.; Baeten, D.L. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Res. Ther. 2012, 14, R74. [CrossRef] [PubMed]
29. Durafourt, B.A.; Moore, C.S.; Zammit, D.A.; Johnson, T.A.; Zaguia, F.; Guiot, M.C.; Bar-Or, A.; Antel, J.P. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 2012, 60, 717–727. [CrossRef] [PubMed]
30. Barros, M.H.; Hauck, F.; Dreyer, J.H.; Kempkes, B.; Niedobitek, G. Macrophage polarisation: An immunohistochemical approach for identifying M1 and M2 macrophages. PLoS ONE 2013, 8, e80908. [CrossRef] [PubMed]
31. Iqbal, C.A.; Kumar, A. Characterization of in vitro generated human polarized macrophages. J. Clin. Cell Immunol. 2015, 6, 380. [CrossRef]
32. Duluc, D.; Delneste, Y.; Tan, F.; Moles, M.P.; Grimaud, L.; Lenoir, J.; Preisser, L.; Anegon, I.; Catala, L.; Ifrah, N.; et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007, 110, 4319–4330. [CrossRef] [PubMed]
33. Pannellini, T.; Iezzi, M.; Di Carlo, E.; Eleuterio, E.; Coletti, A.; Modesti, A.; Rosini, S.; Neri, M.; Musiani, P. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol. 2004, 17, 171–180. [CrossRef] [PubMed]
34. Sunakawa, Y.; Stintzing, S.; Cao, S.; Heinemann, V.; Cremolini, C.; Falcone, A.; Yang, D.; Zhang, W.; Ning, Y.; Stremitzer, S.; et al. Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: Results from tribe and fire3 trials. Ann. Oncol. 2015, 26, 2450–2456. [CrossRef] [PubMed]
35. Wu, H.; Xu, J.B.; He, Y.L.; Peng, J.J.; Zhang, X.H.; Chen, C.Q.; Li, W.; Cai, S.R. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J. Surg. Oncol. 2012, 106, 462–468. [CrossRef] [PubMed]
36. Schraufstatter, I.U.; Zhao, M.; Khaldoyanidi, S.K.; Discipio, R.G. The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology 2012, 135, 287–298. [CrossRef] [PubMed]
37. Zhang, B.; Yao, G.; Zhang, Y.; Gao, J.; Yang, B.; Rao, Z. M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics 2011, 66, 1879–1886. [CrossRef] [PubMed]
38. Bogels, M.; Braster, R.; Nijland, P.G.; Gul, N.; van de Luijtgaarden, W.; Fijneman, R.J.; Meijer, G.A.; Jimenez, C.R.; Beelen, R.H.; van Egmond, M. Carcinoma origin dictates differential skewing of monocyte function. Oncoimmunology 2012, 1, 798–809. [CrossRef] [PubMed]
39. Yuan, A.; Hsiao, Y.J.; Chen, H.Y.; Chen, H.W.; Ho, C.C.; Chen, Y.Y.; Liu, Y.C.; Hong, T.H.; Yu, S.L.; Chen, J.J.; et al. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci. Rep. 2015, 5, 14273. [CrossRef] [PubMed]
40. Patel, U.; Rajasingh, S.; Samanta, S.; Cao, T.; Dawn, B.; Rajasingh, J. Macrophage polarization in response to epigenetic modifiers during infection and inflammation. Drug Discov. Today 2017, 22, 186–193. [CrossRef] [PubMed]
41. Madore, A.M.; Perron, S.; Turmel, V.; Laviolette, M.; Bissonnette, E.Y.; Laprise, C. Alveolar macrophages in allergic asthma: An expression signature characterized by heat shock protein pathways. Hum. Immunol. 2010, 71, 144–150. [CrossRef] [PubMed]
42. Shaykhiev, R.; Krause, A.; Salit, J.; Strulovici-Barel, Y.; Harvey, B.G.; O’Connor, T.P.; Crystal, R.G. Smoking-dependent reprogramming of alveolar macrophage polarization: Implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 2009, 183, 2867–2883. [CrossRef] [PubMed]
43. Stoger, J.L.; Gijbels, M.J.; van der Velden, S.; Manca, M.; van der Loos, C.M.; Biessen, E.A.; Daemen, M.J.; Lutgens, E.; de Winther, M.P. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012, 225, 461–468. [CrossRef] [PubMed]
44. Fukui, S.; Iwamoto, N.; Takatani, A.; Igawa, T.; Shimizu, T.; Umeda, M.; Nishino, A.; Horai, Y.; Hirai, Y.; Koga, T. et al. M1 and M2 monocytes in rheumatoid arthritis: A contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front. Immunol. 2017, 8, 1958. [CrossRef] [PubMed]
45. Arnold, L.; Henry, A.; Poron, F.; Baba-Amer, Y.; van Rooijen, N.; Plonquet, A.; Gherardi, R.K.; Chazaud, B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 2007, 204, 1057–1069. [CrossRef] [PubMed]
46. Ren, Y.; Khan, F.A.; Pandupuspitasari, N.S.; Zhang, S. Immune evasion strategies of pathogens in macrophages: The potential for limiting pathogen transmission. Curr. Issues Mol. Biol. 2017, 21, 21–40. [PubMed]
47. Chandra, V.; Mahajan, S.; Saini, A.; Dkhar, H.K.; Nanduri, R.; Raj, E.B.; Kumar, A.; Gupta, P. Human il10 gene repression by rev-erbalpha ameliorates mycobacterium tuberculosis clearance. J. Biol. Chem. 2013, 288, 10692–10702. [CrossRef] [PubMed]
48. Ting, L.M.; Kim, A.C.; Cattamanchi, A.; Ernst, J.D. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 1999, 163, 3898–3906. [PubMed]
49. Tang, Y.; Hua, S.C.; Qin, G.X.; Xu, L.J.; Jiang, Y.F. Different subsets of macrophages in patients with new onset tuberculous pleural effusion. PLoS ONE 2014, 9, e88343. [CrossRef] [PubMed]
50. Mattila, J.T.; Ojo, O.O.; Kepka-Lenhart, D.; Marino, S.; Kim, J.H.; Eum, S.Y.; Via, L.E.; Barry, C.E., 3rd; Klein, E.; Kirschner, D.E.; et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J. Immunol. 2013, 191, 773–784. [CrossRef] [PubMed]
51. Huang, Z.; Luo, Q.; Guo, Y.; Chen, J.; Xiong, G.; Peng, Y.; Ye, J.; Li, J. Mycobacterium tuberculosis-induced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro. PLoS ONE 2015, 10, e0129744. [CrossRef] [PubMed]
52. Quiding-Jarbrink, M.; Raghavan, S.; Sundquist, M. Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS ONE 2010, 5, e15018. [CrossRef] [PubMed]
53. Fehlings, M.; Drobbe, L.; Moos, V.; Renner Viveros, P.; Hagen, J.; Beigier-Bompadre, M.; Pang, E.; Belogolova, E.; Churin, Y.; Schneider, T.; et al. Comparative analysis of the interaction of helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect. Immun. 2012, 80, 2724–2734. [CrossRef] [PubMed]
54. Saliba, A.E.; Li, L.; Westermann, A.J.; Appenzeller, S.; Stapels, D.A.; Schulte, L.N.; Helaine, S.; Vogel, J. Single-cell RNA-seq ties macrophage polarization to growth rate of intracellular salmonella. Nat. Microbiol. 2016, 2, 16206. [CrossRef] [PubMed]
55. Thompson, L.J.; Dunstan, S.J.; Dolecek, C.; Perkins, T.; House, D.; Dougan, G.; Nguyen, T.H.; Tran, T.P.; Doan, C.D.; Le, T.P.; et al. Transcriptional response in the peripheral blood of patients infected with salmonella enterica serovar typhi. Proc. Natl. Acad. Sci. USA 2009, 106, 22433–22438. [CrossRef] [PubMed]
56. Reales-Calderon, J.A.; Aguilera-Montilla, N.; Corbi, A.L.; Molero, G.; Gil, C. Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to candida albicans. Proteomics 2014, 14, 1503–1518. [CrossRef] [PubMed]
57. Wagener, J.; MacCallum, D.M.; Brown, G.D.; Gow, N.A. Candida albicans chitin increases arginase-1 activity in human macrophages, with an impact on macrophage antimicrobial functions. MBio 2017, 8, e01820-16. [CrossRef] [PubMed]
58. Cassol, E.; Cassetta, L.; Alfano, M.; Poli, G. Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 2010, 87, 599–608. [CrossRef] [PubMed]
59. Brockman, M.A.; Kwon, D.S.; Tighe, D.P.; Pavlik, D.F.; Rosato, P.C.; Sela, J.; Porichis, F.; Le Gall, S.; Waring, M.T.; Moss, K.; et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009, 114, 346–356. [CrossRef] [PubMed]
60. Flynn, J.K.; Dore, G.J.; Hellard, M.; Yeung, B.; Rawlinson, W.D.; White, P.A.; Kaldor, J.M.; Lloyd, A.R.; Ffrench, R.A. Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J. Viral. Hepat. 2011, 18, 549–561. [CrossRef] [PubMed]
61. Zhang, Q.; Wang, Y.; Zhai, N.; Song, H.; Li, H.; Yang, Y.; Li, T.; Guo, X.; Chi, B.; Niu, J.; et al. HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway. Sci. Rep. 2016, 6, 36160. [CrossRef] [PubMed]
62. Saha, B.; Kodys, K.; Szabo, G. Hepatitis C virus-induced monocyte differentiation into polarized M2 macrophages promotes stellate cell activation via TGF-β. Cell. Mol. Gastroenterol. Hepatol. 2016, 2, 302–316. [CrossRef] [PubMed]
63. Hoeve, M.A.; Nash, A.A.; Jackson, D.; Randall, R.E.; Dransfield, I. Influenza virus a infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS ONE 2012, 7, e29443. [CrossRef] [PubMed]
64. Zhang, N.; Bao, Y.J.; Tong, A.H.; Zuyderduyn, S.; Bader, G.D.; Malik Peiris, J.S.; Lok, S.; Lee, S.M. Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza a H5N1 virus infection. BMC Med. Genom. 2018, 11, 20. [CrossRef] [PubMed]
65. Chan, G.; Bivins-Smith, E.R.; Smith, M.S.; Smith, P.M.; Yurochko, A.D. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 2008, 181, 698–711. [CrossRef] [PubMed]
66. Chan, G.; Nogalski, M.T.; Yurochko, A.D. Human cytomegalovirus stimulates monocyte-to-macrophage differentiation via the temporal regulation of caspase 3. J. Virol. 2012, 86, 10714–10723. [CrossRef] [PubMed]
67. Avdic, S.; Cao, J.Z.; McSharry, B.P.; Clancy, L.E.; Brown, R.; Steain, M.; Gottlieb, D.J.; Abendroth, A.; Slobedman, B. Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J. Virol. 2013, 87, 10273–10282. [CrossRef] [PubMed]
68. Poglitsch, M.; Weichhart, T.; Hecking, M.; Werzowa, J.; Katholnig, K.; Antlanger, M.; Krmpotic, A.; Jonjic, S.; Horl, W.H.; Zlabinger, G.J.; et al. CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. Am. J. Transplant. 2012, 12, 1458–1468. [CrossRef] [PubMed]
69. Cassol, E.; Cassetta, L.; Rizzi, C.; Alfano, M.; Poli, G. M1 and M2A polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J. Immunol. 2009, 182, 6237–6246. [CrossRef] [PubMed]
70. Herbein, G.; Varin, A. The macrophage in HIV-1 infection: From activation to deactivation? Retrovirology 2010, 7, 33. [CrossRef] [PubMed]
71. Liu, Y.C.; Zou, X.B.; Chai, Y.F.; Yao, Y.M. Macrophage polarization in inflammatory diseases. Int. J. Biol. Sci. 2014, 10, 520–529. [CrossRef] [PubMed]
72. Almeida, S.; Nejsum, P.; Williams, A.R. Modulation of human macrophage activity by ascaris antigens is dependent on macrophage polarization state. Immunobiology 2018, 223, 405–412. [CrossRef] [PubMed]
73. Kimutai, A.; Ngure, P.K.; Tonui, W.K.; Gicheru, M.M.; Nyamwamu, L.B. Leishmaniasis in northern and western africa: A review. Afr. J. Infect. Dis. 2009, 3, 14–25. [CrossRef]
74. Louzir, H.; Aoun, K.; Spath, G.F.; Laouini, D.; Prina, E.; Victoir, K.; Bouratbine, A. Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of pasteur institutes. Med. Sci. 2013, 29, 1151–1160.
75. Olivier, M.; Gregory, D.J.; Forget, G. Subversion mechanisms by which leishmania parasites can escape the host immune response: A signaling point of view. Clin. Microbiol. Rev. 2005, 18, 293–305. [CrossRef] [PubMed]
76. Kropf, P.; Fuentes, J.M.; Fahnrich, E.; Arpa, L.; Herath, S.; Weber, V.; Soler, G.; Celada, A.; Modolell, M.; Muller, I. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005, 19, 1000–1002. [CrossRef] [PubMed]
77. Guerfali, F.Z.; Laouini, D.; Guizani-Tabbane, L.; Ottones, F.; Ben-Aissa, K.; Benkahla, A.; Manchon, L.; Piquemal, D.; Smandi, S.; Mghirbi, O.; et al. Simultaneous gene expression profiling in human macrophages infected with leishmania major parasites using sage. BMC Genom. 2008, 9, 238. [CrossRef] [PubMed]
78. Murray, P.J.; Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11, 723–737. [CrossRef] [PubMed]
79. Liu, D.; Uzonna, J.E. The early interaction of leishmania with macrophages and dendritic cells and its influence on the host immune response. Front. Cell. Infect. Microbiol. 2012, 2, 83. [CrossRef] [PubMed]
80. Muraille, E.; Leo, O.; Moser, M. TH1/TH2 paradigm extended: Macrophage polarization as an unappreciated pathogen-driven escape mechanism? Front. Immunol. 2014, 5, 603. [CrossRef] [PubMed]
81. Maspi, N.; Abdoli, A.; Ghaffarifar, F. Pro-and anti-inflammatory cytokines in cutaneous leishmaniasis: A review. Pathog. Glob. Health 2016, 110, 247–260. [CrossRef] [PubMed]
82. Farrow, A.L.; Rana, T.; Mittal, M.K.; Misra, S.; Chaudhuri, G. Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages. Mol. Cell. Biochem. 2011, 350, 47–57. [CrossRef] [PubMed]
83. Mukhopadhyay, D.; Mukherjee, S.; Roy, S.; Dalton, J.E.; Kundu, S.; Sarkar, A.; Das, N.K.; Kaye, P.M.; Chatterjee, M. M2 polarization of monocytes-macrophages is a hallmark of indian post kala-azar dermal leishmaniasis. PLoS Negl. Trop. Dis. 2015, 9, e0004145. [CrossRef] [PubMed]
84. Kong, F.; Saldarriaga, O.A.; Spratt, H.; Osorio, E.Y.; Travi, B.L.; Luxon, B.A.; Melby, P.C. Transcriptional profiling in experimental visceral leishmaniasis reveals a broad splenic inflammatory environment that conditions macrophages toward a disease-promoting phenotype. PLoS Pathog. 2017, 13, e1006165. [CrossRef] [PubMed]